Insider Purchases: Inside the Buy

Tag: ShortSqueeze

Split image showing Corcept Therapeutics stock volatility: one side with a red falling chart and FDA rejection stamp, the other with a green rising chart and glowing biotech lab vial, symbolizing high-risk, high-reward biotech investing.

CORT Stock 2026: FDA Rejection, Insider Buying… and a Brewing Short Squeeze?

Corcept Therapeutics just got hit with an FDA rejection—but insiders are buying millions and short interest is surging. With a profitable base business and major 2026 catalysts ahead, CORT may be one of the most explosive “binary bets” in biotech today.

Read entire article

Tags: Biotech Investing, Biotech Picks, Biotech Stocks, BiotechGrowth, BiotechInvesting, BiotechStocks, buy or sell CORT, Corcept Therapeutics, CorceptTherapeutics, CORT, CORT stock, FDA rejection, featured-insiders, FUNanc1al investing, Growth stocks, Healthcare investing, High risk high reward, hub-insiders, Insider buying, InsiderTrading, OvarianCancerResearch, Relacorilant, risks buying CORT, Short squeeze, ShortSqueeze, Stock analysis 2026, StockMarket2026, why buy CORT
Illustration of a ski mountain shaped like a falling stock chart with a skier buying shares while bears chase and a crowded lift labeled institutional ownership, symbolizing Vail Resorts stock dynamics.

MTN Stock Analysis 2026: Why Rob Katz’s $5M Buy Signals a Peak Opportunity in Vail Resorts

Vail Resorts (MTN) just endured one of the worst snowfall seasons in decades—yet insiders are buying millions in stock. With a powerful Epic Pass model, heavy institutional ownership, and rising short interest, this mountain stock may be setting up for a contrarian move.

Read entire article

Tags: buy or sell MTN, CEO Buyin, CEO buys shares, CEO confidence, CEO insider buy, Consumer discretionary, contrarian investment, Dividend stocks, EpicPass, featured-insiders, FUNanc1al, hub-insiders, Insider buying, InsiderBuying, Leisure stocks, MTN, MTN stock, risks buying MTN, Short squeeze, ShortSqueeze, SkiIndustry, Stock market analysis, StockMarket2026, Travel stocks, Vail Resorts, VailResorts, Value investing, ValueInvesting, why buy MTN